• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2012 年冈比亚 W135 群脑膜炎球菌病。

Serogroup W135 meningococcal disease, The Gambia, 2012.

出版信息

Emerg Infect Dis. 2013;19(9):1507-10. doi: 10.3201/eid1909.130077.

DOI:10.3201/eid1909.130077
PMID:23965435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3810914/
Abstract

In 2012, an outbreak of Neisseria meningitidis serogroup W135 occurred in The Gambia. The attack rate was highest among young children. The associated risk factors were male sex, contact with meningitis patients, and difficult breathing. Enhanced surveillance facilitates early epidemic detection, and multiserogroup conjugate vaccine could reduce meningococcal epidemics in The Gambia.

摘要

2012 年，脑膜炎奈瑟菌 W135 血清群在冈比亚爆发。发病率在儿童中最高。相关的危险因素是男性、与脑膜炎患者接触和呼吸困难。加强监测有助于及早发现疫情，多价结合疫苗可减少冈比亚的脑膜炎流行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c61/3810914/23129067a542/13-0077-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c61/3810914/d834e3682226/13-0077-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c61/3810914/23129067a542/13-0077-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c61/3810914/d834e3682226/13-0077-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c61/3810914/23129067a542/13-0077-F2.jpg

相似文献

1
Serogroup W135 meningococcal disease, The Gambia, 2012.2012 年冈比亚 W135 群脑膜炎球菌病。
Emerg Infect Dis. 2013;19(9):1507-10. doi: 10.3201/eid1909.130077.
2
Outbreak of serotype W135 Neisseria meningitidis in central river region of the Gambia between February and June 2012: a hospital-based review of paediatric cases.2012年2月至6月冈比亚中部河区W135群脑膜炎奈瑟菌暴发：基于医院的儿科病例回顾
Niger J Clin Pract. 2015 Jan-Feb;18(1):41-7. doi: 10.4103/1119-3077.146977.
3
Meningitis serogroup W135 outbreak, Burkina Faso, 2002.2002年，布基纳法索W135群脑膜炎暴发。
Emerg Infect Dis. 2007 Jun;13(6):920-3. doi: 10.3201/eid1306.060940.
4
Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135.2003年和2004年尼日尔脑膜炎球菌性脑膜炎的流行病学模式：在W135群脑膜炎奈瑟菌的威胁之下
Trop Med Int Health. 2005 May;10(5):435-43. doi: 10.1111/j.1365-3156.2005.01394.x.
5
Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.非洲脑膜炎带中的W135群脑膜炎球菌：流行病学、免疫与疫苗
Expert Rev Vaccines. 2006 Jun;5(3):319-36. doi: 10.1586/14760584.5.3.319.
6
The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005.2002 - 2005年布基纳法索流行性W135群脑膜炎奈瑟菌脑膜炎的兴衰
Clin Infect Dis. 2006 Oct 1;43(7):817-22. doi: 10.1086/507339. Epub 2006 Aug 22.
7
Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso.一场疫情的预纪事：布基纳法索的W135群脑膜炎球菌性脑膜炎
Lancet Infect Dis. 2002 Dec;2(12):763-5. doi: 10.1016/s1473-3099(02)00455-3.
8
Serogroup W135 meningococcal meningitis, Northern Cameroon, 2007-2008.2007 - 2008年，喀麦隆北部，W135群脑膜炎球菌性脑膜炎
Emerg Infect Dis. 2009 Feb;15(2):340-2. doi: 10.3201/eid1502.080988.
9
Travel-related Neisseria meningitidis serogroup W135 infection, France.法国与旅行相关的W135群脑膜炎奈瑟菌感染
Emerg Infect Dis. 2013 Jun;19(6):1030-2. doi: 10.3201/eid1906.120515.
10
The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37/ST-11 as an epidemic clone and the persistence of serogroup A isolates in Burkina Faso.克隆复合体ET-37/ST-11的脑膜炎奈瑟菌W135血清群作为流行克隆的出现以及A血清群菌株在布基纳法索的持续存在。
Microbes Infect. 2005 Apr;7(4):645-9. doi: 10.1016/j.micinf.2005.01.003. Epub 2005 Mar 17.

引用本文的文献

1
The epidemiology of infectious meningitis in Ghana: a systematic review and meta-analysis.加纳感染性脑膜炎的流行病学：系统评价与荟萃分析。
BMC Public Health. 2025 Aug 6;25(1):2671. doi: 10.1186/s12889-025-22476-y.
2
Cohort Profile: Basse Health and Demographic Surveillance System, the Gambia.队列简介：冈比亚巴斯健康与人口监测系统
Int J Epidemiol. 2025 Feb 16;54(2). doi: 10.1093/ije/dyaf021.
3
Evaluation of Dried Blood and Cerebrospinal Fluid Filter Paper Spots for Storing and Transporting Clinical Material for the Molecular Diagnosis of Invasive Meningococcal Disease.

本文引用的文献

1
Meningococcal disease in countries of the African meningitis belt, 2012 - emerging needs and future perspectives.2012年非洲脑膜炎带国家的脑膜炎球菌病——新出现的需求和未来展望
Wkly Epidemiol Rec. 2013 Mar 22;88(12):129-36.
2
Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.脑膜炎球菌病研究重点及 A 群脑膜炎球菌疫苗接种对非洲脑膜炎地带的影响。
Vaccine. 2013 Mar 1;31(11):1453-7. doi: 10.1016/j.vaccine.2012.12.035. Epub 2012 Dec 27.
3
Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.
评价用于储存和运输侵袭性脑膜炎奈瑟菌病分子诊断临床标本的干血滤纸片和脑脊液滤纸片。
Int J Mol Sci. 2022 Oct 6;23(19):11879. doi: 10.3390/ijms231911879.
4
Childhood meningitis in rural Gambia: 10 years of population-based surveillance.冈比亚农村儿童期脑膜炎：10 年基于人群的监测。
PLoS One. 2022 Aug 10;17(8):e0265299. doi: 10.1371/journal.pone.0265299. eCollection 2022.
5
Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination.脑膜炎球菌病暴发：一个不断变化的目标及常规预防性疫苗接种的理由
Infect Dis Ther. 2021 Dec;10(4):1949-1988. doi: 10.1007/s40121-021-00499-3. Epub 2021 Aug 11.
6
Changes in the Molecular Epidemiology of Pediatric Bacterial Meningitis in Senegal After Pneumococcal Conjugate Vaccine Introduction.塞内加尔引入肺炎球菌结合疫苗后小儿细菌性脑膜炎的分子流行病学变化。
Clin Infect Dis. 2019 Sep 5;69(Suppl 2):S156-S163. doi: 10.1093/cid/ciz517.
7
Declining Trends of Pneumococcal Meningitis in Gambian Children After the Introduction of Pneumococcal Conjugate Vaccines.冈比亚儿童在引入肺炎球菌结合疫苗后，肺炎球菌性脑膜炎的发病趋势下降。
Clin Infect Dis. 2019 Sep 5;69(Suppl 2):S126-S132. doi: 10.1093/cid/ciz505.
8
Analysis of a meningococcal meningitis outbreak in Niger - potential effectiveness of reactive prophylaxis.尼日尔脑膜炎球菌性脑膜炎疫情分析 - 反应性预防的潜在效果。
PLoS Negl Trop Dis. 2019 Mar 11;13(3):e0007077. doi: 10.1371/journal.pntd.0007077. eCollection 2019 Mar.
9
Emergence of Neisseria meningitidis Serogroup W, Central African Republic, 2015-2016.2015-2016 年中非共和国脑膜炎奈瑟菌 W 群的出现。
Emerg Infect Dis. 2018 Nov;24(11):2080-2083. doi: 10.3201/eid2411.170817.
10
Increase in serogroup W invasive disease in Canada: 2009-2016.2009 - 2016年加拿大W血清群侵袭性疾病增加情况
Can Commun Dis Rep. 2017 Jul 6;43(7-8):144-149. doi: 10.14745/ccdr.v43i78a01.
A 群脑膜炎球菌结合疫苗（MenAfriVac）对带菌和群体免疫的影响。
Clin Infect Dis. 2013 Feb;56(3):354-63. doi: 10.1093/cid/cis892. Epub 2012 Oct 19.
4
Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.布基纳法索 A 群脑膜炎球菌结合疫苗接种：国家监测数据分析。
Lancet Infect Dis. 2012 Oct;12(10):757-64. doi: 10.1016/S1473-3099(12)70168-8. Epub 2012 Jul 18.
5
Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: design and implementation of a population-based surveillance system.监测肺炎球菌结合疫苗在西非的引入情况：基于人群的监测系统的设计与实施。
PLoS Med. 2012 Jan;9(1):e1001161. doi: 10.1371/journal.pmed.1001161. Epub 2012 Jan 17.
6
Increase in Neisseria meningitidis serogroup W135, Niger, 2010.2010年，尼日尔，脑膜炎奈瑟菌W135血清群感染病例增加。
Emerg Infect Dis. 2010 Sep;16(9):1496-8. doi: 10.3201/eid1609.100510.
7
Meningitis serogroup W135 outbreak, Burkina Faso, 2002.2002年，布基纳法索W135群脑膜炎暴发。
Emerg Infect Dis. 2007 Jun;13(6):920-3. doi: 10.3201/eid1306.060940.
8
Enhanced surveillance of epidemic meningococcal meningitis in Africa: a three-year experience.非洲流行性脑膜炎强化监测：三年经验
Wkly Epidemiol Rec. 2005 Sep 16;80(37):313-20.
9
Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study.朝觐者中W135型脑膜炎球菌携带情况及其向家庭接触者的传播：前瞻性研究
BMJ. 2002 Aug 17;325(7360):365-6. doi: 10.1136/bmj.325.7360.365.
10
Risk factors for meningococcal meningitis in northern Ghana.加纳北部地区脑膜炎球菌性脑膜炎的风险因素。
Trans R Soc Trop Med Hyg. 2001 Sep-Oct;95(5):477-80. doi: 10.1016/s0035-9203(01)90007-0.